ProShare Advisors
TVGN icon

ProShare Advisors’s Tevogen Bio Holdings TVGN Stock Holding History

ProShare Advisors’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-242
Closed -$9.51K – 2101
2025
Q3 		$9.51K Sell
242
-12
-5% -$590 ﹤0.01% 2005
2025
Q2 		$15.8K Sell
254
-5
-2% -$285 ﹤0.01% 2074
2025
Q1 		$14K Sell
259
-35
-12% -$2.3K ﹤0.01% 2055
2024
Q4 		$15.1K Buy
+294
New +$19.2K ﹤0.01% 2259

Other funds holding TVGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ProShare Advisors's TVGN Position: Q4 2025 in Review

ProShare Advisors sold out of Tevogen Bio Holdings (TVGN) in Q4 2025, closing a stake of 242 shares — an estimated $9.51K sold.

ProShare Advisors first reported a position in TVGN in Q4 2024 and held it in 4 quarters. The position peaked at $15.8K in Q2 2025. 51 funds tracked by Wall St. Rank hold TVGN as of Q4 2025.

  • ProShare Advisors reported no remaining Tevogen Bio Holdings position as of Q4 2025 after selling out during the quarter.
  • ProShare Advisors sold 242 Tevogen Bio Holdings shares in Q4 2025, an estimated $9.51K.
  • ProShare Advisors first reported a position in Tevogen Bio Holdings in Q4 2024 and held it in 4 quarters.
  • ProShare Advisors's Tevogen Bio Holdings position peaked at $15.8K in Q2 2025.
  • 51 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q4 2025.

Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.